Awaiting FDA Reclassification

KPV Therapy

Anti-Inflammatory & Gut Health

KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Despite being just three amino acids long, it demonstrates potent anti-inflammatory properties, particularly in the gut.

Pending FDA Reclassification

KPV is currently classified as a Category 2 peptide by the FDA, meaning it cannot yet be compounded by US pharmacies for patient use. In February 2026, HHS signaled intent to reclassify up to 14 peptides back to Category 1 — which would allow licensed compounding pharmacies to prepare them under physician prescription. We are closely monitoring this process.

Be First in Line for KPV

Join the waitlist and we'll notify you the moment physician-guided KPV therapy becomes available through Zelvimed.

No spam. Unsubscribe anytime. We'll only email you when KPV becomes available.

You're on the list! We'll notify you as soon as KPV is available.

Why KPV?

What the research says about KPV (Lysine-Proline-Valine)

P

Powerful Anti-Inflammatory

KPV inhibits inflammatory pathways (NF-κB) at the cellular level, making it one of the most targeted anti-inflammatory peptides studied.

G

Gut & Intestinal Health

Research shows particular promise for inflammatory bowel conditions — KPV may help reduce intestinal inflammation and support gut barrier integrity.

S

Skin Health

As a derivative of α-MSH, KPV has shown potential for managing inflammatory skin conditions and promoting skin healing.

A

Antimicrobial Properties

Studies suggest KPV may have direct antimicrobial effects, helping the body combat certain bacterial and fungal infections.

Who is KPV For?

Individuals with gut inflammation, those dealing with autoimmune-related inflammation, and people seeking targeted anti-inflammatory support without immunosuppression.

Don't Miss the Window

When KPV becomes available, demand will be high. Get on the waitlist now to secure early access to physician-guided therapy through Zelvimed.

Join 0 others waiting for KPV access.

You're on the list! We'll notify you as soon as KPV is available.